Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iduna Fichtner

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Scientific Reports|February 7, 2018
Loss-of-function uORF mutations in human malignanciesJulia Schulz, Nancy Mah, Martin Neuenschwander, et al.
Blood|November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphomaAndre Weilemann, Michael Grau, Tabea Erdmann, et al.
Genome Medicine|July 22, 2018
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistanceSabrina Grasse, Matthias Lienhard, Steffen Frese, et al.
International Journal of Cancer|August 5, 2011
High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in RussiaAnna P Sokolenko, Aglaya G Iyevleva, Elena V Preobrazhenskaya, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Scientific Reports|February 7, 2018
Loss-of-function uORF mutations in human malignanciesJulia Schulz, Nancy Mah, Martin Neuenschwander, et al.
Blood|November 1, 2014
Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphomaAndre Weilemann, Michael Grau, Tabea Erdmann, et al.
Genome Medicine|July 22, 2018
Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistanceSabrina Grasse, Matthias Lienhard, Steffen Frese, et al.
International Journal of Cancer|August 5, 2011
High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in RussiaAnna P Sokolenko, Aglaya G Iyevleva, Elena V Preobrazhenskaya, et al.
Pageof 12